Friday - July 18, 2025

LOGIN  |  REGISTER
Cue Biopharma
C4 Therapeutics

U.S. Physical Therapy Schedules Fourth Quarter and Year Ended December 31, 2024 Earnings Release and Conference Call Dates

February 20, 2025 | Last Trade: US$74.95 1.22 1.65

HOUSTON / Feb 20, 2025 / Business Wire / U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the fourth quarter and year ended December 31, 2024, on Wednesday, February 26, 2025, after the stock market closes, with the conference call to follow the next morning, on Thursday, February 27, 2025.

Conference Call

Date:

Thursday, February 27, 2025

 

Time:

10:30 am Eastern/9:30 am Central
 

Dial-In Number:

(800) 445-7795 Primary or
 

 

(785) 424-1699 Alternate
 

Conference ID:

USPHQ424
 

(In order to join this conference call, you will be required to provide the Conference ID listed above)

To participate, please call in 15 minutes prior to start time. 

To listen to the live call, please go to www.usph.com and click on conference calls under the Investor Relations section. Please go to the website 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, a playback of the conference call can be accessed until May 28, 2025, at U.S. Physical Therapy’s website.

About U.S. Physical Therapy, Inc.

Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 772 outpatient physical therapy clinics in 43 states. USPH clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. USPH also has an industrial injury prevention business which provides onsite services for clients’ employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments.

More information about U.S. Physical Therapy, Inc. is available at www.usph.com. The information included on that website is not incorporated into this press release.

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page